Indications
Ridicef is indicated for the treatment of Community Acquired Pneumonia, Acute Exacerbations of Chronic Bronchitis, Acute Maxillary Sinusitis, Pharyngitis/Tonsillitis, Acute Bacterial Otitis Media, and Uncomplicated Skin and Skin Structure Infections.
⚠️ Always consult a registered physician before taking any medicine.
Pharmacology
Cefdinir is a semisynthetic third generation oral cephalosporin antibotic. It has a broad spectrum bactericidal activity against a wide range of common pathogens, including b-lactamase producing strains like Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Moraxella catarrhalis, E. coli, Klebsiella pneumoniae, and Proteus mirabilis. As with other cephalosporins, bactericidal activity of Cefexta results from inhibition of cell wall synthesis.
Pregnancy & Breastfeeding
Its pregnancy category is B, though there are no adequate, well-controlled studies in pregnant women, so Cefdinir should be used in pregnancy only when clearly needed. In studies where a single 600 mg dose was given, it was not detected in breast milk.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Dosage Reference
⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.